Equity benchmarks started with sharp gains after the Food and Drug Administration granted “fast track” status to a pair of vaccine candidates produced by Pfizer and German biotech firm BioNTech SE.A rally in technology and tech-related companies that propelled the Nasdaq Composite to a new intraday high on Monday faded in afternoon trade, leaving the benchmark and S&P 500 index both firmly in negative territory at the closing bell.